Compare PMTS & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PMTS | SOPH |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | Switzerland |
| Employees | 1700 | N/A |
| Industry | Finance Companies | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 333.8M | 462.3M |
| IPO Year | 2015 | 2021 |
| Metric | PMTS | SOPH |
|---|---|---|
| Price | $28.83 | $8.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $27.67 | $7.50 |
| AVG Volume (30 Days) | 103.1K | ★ 526.2K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.34 | N/A |
| Revenue | ★ $312,189,000.00 | N/A |
| Revenue This Year | $9.95 | $23.09 |
| Revenue Next Year | $10.02 | $19.57 |
| P/E Ratio | $85.15 | ★ N/A |
| Revenue Growth | ★ 12.27 | N/A |
| 52 Week Low | $10.81 | $3.10 |
| 52 Week High | $31.25 | $8.98 |
| Indicator | PMTS | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 66.39 | 70.10 |
| Support Level | $27.00 | $4.63 |
| Resistance Level | $31.25 | N/A |
| Average True Range (ATR) | 1.21 | 0.39 |
| MACD | -0.19 | 0.06 |
| Stochastic Oscillator | 39.77 | 83.85 |
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit segment, which principally produce secure debit and credit cards and provide card services for U.S. card-issuing financial institutions, including personalization, instant issuance and other payment solutions such as digital push provisioning for mobile wallets; Prepaid Debit, which provides secure packaging solutions, Prepaid Debit Cards, and other integrated prepaid card services to prepaid program managers in the U.S.; and other: principally corporate expenses. The firm generates key revenue from Debit and Credit segment.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.